Y

Yili Chuanning Biotechnology Co Ltd
SZSE:301301

Watchlist Manager
Yili Chuanning Biotechnology Co Ltd
SZSE:301301
Watchlist
Price: 12.8 CNY -5.26% Market Closed
Market Cap: 28.5B CNY
Have any thoughts about
Yili Chuanning Biotechnology Co Ltd?
Write Note

Yili Chuanning Biotechnology Co Ltd
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Yili Chuanning Biotechnology Co Ltd
Net Income (Common) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Y
Yili Chuanning Biotechnology Co Ltd
SZSE:301301
Net Income (Common)
ÂĄ940.6m
CAGR 3-Years
60%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Net Income (Common)
-ÂĄ6.7B
CAGR 3-Years
16%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Net Income (Common)
ÂĄ1.2B
CAGR 3-Years
23%
CAGR 5-Years
34%
CAGR 10-Years
N/A
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Net Income (Common)
ÂĄ1.8B
CAGR 3-Years
5%
CAGR 5-Years
N/A
CAGR 10-Years
23%
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Net Income (Common)
ÂĄ6B
CAGR 3-Years
-6%
CAGR 5-Years
26%
CAGR 10-Years
48%
Imeik Technology Development Co Ltd
SZSE:300896
Net Income (Common)
ÂĄ1.9B
CAGR 3-Years
62%
CAGR 5-Years
72%
CAGR 10-Years
N/A
No Stocks Found

Yili Chuanning Biotechnology Co Ltd
Glance View

Market Cap
28.5B CNY
Industry
Biotechnology

Yili Chuanning Biotechnology Co., Ltd. engages in biological fermentation, chemical extraction, enzymatic hydrolysis, energy saving, and environmental protection technology. The company is headquartered in Yili Hasake, Xinjiang and currently employs 2,779 full-time employees. The company went IPO on 2022-12-27. The firm's products mainly include erythromycin thiocyanate, cephalosporin intermediates, penicillin intermediates, crude ursodeoxycholic acid, coenzyme Q10 mycelium and others. The firm's products are mainly exported to countries such as India.

Intrinsic Value
16.92 CNY
Undervaluation 24%
Intrinsic Value
Price
Y

See Also

What is Yili Chuanning Biotechnology Co Ltd's Net Income (Common)?
Net Income (Common)
940.6m CNY

Based on the financial report for Dec 31, 2023, Yili Chuanning Biotechnology Co Ltd's Net Income (Common) amounts to 940.6m CNY.

What is Yili Chuanning Biotechnology Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 3Y
60%

Over the last year, the Net Income (Common) growth was 129%. The average annual Net Income (Common) growth rates for Yili Chuanning Biotechnology Co Ltd have been 60% over the past three years .

Back to Top